Short-course radiotherapy trials for Rectal Cancer

All Short-course radiotherapy trials · All Rectal Cancer trials

Phase breakdown

Recruiting trials studying Short-course radiotherapy for Rectal Cancer

• A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer
  NCT07113275 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer
  NCT07239466 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Contact Radiotherapy for Rectal Cancer
  NCT06501053 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• SCRT Sequential Penpulimab in Combination With CAPEOX in the Neoadjuvant Treatment of MSS Locally Advanced Rectal Cancer
  NCT05576480 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Total Neoadjuvant Therapy in Rectal Cancer
  NCT06162650 · Phase: Phase 2 · Ages: 20 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Short-course radiotherapy for Rectal Cancer?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.